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Fas apoptotic signaling regulates diverse physiolog-
ical processes. Acute activation of Fas signaling trig-
gers massive apoptosis in liver. Upon Fas receptor
stimulation, the BH3-only protein Bid is cleaved
into the active form, tBid. Subsequent tBid recruit-
ment to mitochondria, which is facilitated by its re-
ceptor MTCH2 at the outer mitochondrial membrane
(OMM), is a critical step for commitment to apoptosis
via the effector proteins Bax or Bak. MOAP-1 is a
Bax-binding protein enriched at the OMM. Here, we
show that MOAP-1-deficient mice are resistant to
Fas-induced hepatocellular apoptosis and lethality.
In the absence of MOAP-1, mitochondrial accumula-
tion of tBid is markedly impaired. MOAP-1 binds to
MTCH2, and this interaction appears necessary for
MTCH2 to engage tBid. These findings reveal a role
for MOAP-1 in Fas signaling in the liver by promoting
MTCH2-mediated tBid recruitment to mitochondria.INTRODUCTION
Fas (also known as CD95 and APO-1) signaling for apoptosis
activation plays important roles in diverse physiological pro-
cesses including regulating homeostasis of the hematopoietic
and immune systems (Peter et al., 2007; Strasser et al., 2009;
Watanabe-Fukunaga et al., 1992). Dysfunction of Fas signaling
has been implicated in a multitude of human diseases such as
autoimmune disorders and liver diseases (Guicciardi and Gores,
2005; Peter et al., 2007). Indeed, elevated expression of Fas re-
ceptor or ligand in livers was frequently observed among pa-
tients suffering from fulminant hepatitis (Galle et al., 1995; Ryo
et al., 2000). Fas activation triggers apoptosis via two distinct
mechanisms dependent on cell types (Jost et al., 2009; Scaffidi174 Cell Reports 16, 174–185, June 28, 2016 ª 2016 The Authors.
This is an open access article under the CC BY-NC-ND license (http://et al., 1998). In type I cells (e.g., thymocytes and lymphocytes),
Fas-induced activation of caspase-8 is sufficient to execute
apoptosis by activating effector caspase-3 and caspase-7.
In type II cells (e.g., hepatocytes and b-pancreatic cells), Fas-
mediated apoptosis requires involvement of the mitochondrial
pathway. Upon activation of the Fas receptor, activated cas-
pase-8 cleaves the BH3-only protein, Bid (Wang et al., 1996),
which is an essential step for inducing Fas-mediated apoptosis
in liver (Lazic et al., 2014; Yin et al., 1999), to yield the activated
form, tBid (also known as p15 Bid) (Li et al., 1998; Luo et al.,
1998). tBid accumulates at outer mitochondrial membrane
(OMM) to promote activation and oligomerization of Bax and
Bak (Gross et al., 1999; Wei et al., 2001). This eventually leads
to mitochondrial outer membrane permeabilization (MOMP)
and releasing of multiple apoptogenic factors including cyto-
chrome c and Smac/DIABLO to the cytosol (Du et al., 2000;
Luo et al., 1998; Verhagen et al., 2000). Cytochrome c forms a
complex with Apaf-1 and caspase-9 that triggers activation of
caspase-3 (Li et al., 1997), Smac in turn releases activated cas-
pase-3 and caspase-7 from inhibition by binding to the inhibitor
of apoptosis proteins (IAPs) (Du et al., 2000; Verhagen et al.,
2000). The recruitment of tBid to mitochondria is thought to be
facilitated by the mitochondria-specific phospholipid cardiolipin
(Esposti et al., 2003; Lutter et al., 2000). More recently, Gross
and colleagues demonstrated that mitochondrial accumulation
of tBid is dependent on its recruitment by an OMM protein, mito-
chondrial carrier homolog 2 (MTCH2, also known asMIMP) (Yer-
ushalmi et al., 2002), which acts as a receptor-like protein for
tBid (Grinberg et al., 2005; Zaltsman et al., 2010).
Modulator of apoptosis-1 (MOAP-1) is a Bax-binding protein
residing at OMM (Fu et al., 2009; Tan et al., 2001, 2005). It is a
short-lived protein that is constitutively regulated by the ubiqui-
tin-proteasome system (UPS) (Fu et al., 2007). Apoptotic stimuli
stabilize MOAP-1 by blocking its poly-ubiquitination process (Fu
et al., 2007) and stimulate its interaction with Bax (Tan et al.,
2005). Levels of MOAP-1 protein can modulate sensitivity of
cancer cells to apoptotic stimuli, as knockdown of MOAP-1creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Generation ofMOAP-1 Knockout Mouse and Evaluation of Sensitivity of the MOAP-1-Deficient MEFs to Multiple Apoptotic Stimuli
(A) Left panel: targeting scheme for theMOAP-1 KO mice. Exon 2 ofMOAP-1 gene, which contains the entire coding region, was replaced with neomycin (Neo)
resistance gene via homologous recombination. EcoRI restriction sites were used for southern blotting with the length of the excised fragment stated in kb pairs,
and the southern blot probes are indicated as Probe 1 and 2 (Probe 1 is specific for the targeted MOAP-1 allele whereas Probe 2 hybridizes with both WT and
targeted MOAP-1 alleles). x, y, and z are the primers used for PCR-based genotyping. Right panel: southern blot analysis demonstrating homologous recom-
bination within MOAP-1 gene locus in the first generation of heterozygous (HET) mouse.
(B) PCR-based genotyping of WT, heterozygous, and MOAP-1 KO animals.
(C) RT-PCR analysis of WT and MOAP-1 KO livers (left) and MEFs (right).
(D)Western analysis of MOAP-1 immunoprecipitated from total liver lysates of theWT andMOAP-1KOmice. HSP60was probed to show equal amount of lysates
used in the IP.
(E) Expression ofMOAP-1 inMEFs derived from theWT orMOAP-1KO littermates. MOAP-1 protein is regulated by the proteasome andwas readily detected only
upon treatment with the proteasome inhibitor MG132 (10 mM) for 16 hr.
(F) MOAP-1 deficiency dampens the sensitivity of MEFs to apoptotic stimuli that act via the mitochondrial pathway. WT andMOAP-1 KOMEFs were treated with
etoposide (5 mM), thapsigargin (10 mM), staurosporine (500 nM), or gamma irradiation (10 gray) for the indicated durations. Cell death was determined using
propidium iodide (PI) exclusion-based flow cytometric analysis. Percentages of cell death (cells uptaking PI) (mean ± SEM of three independent experiments) are
shown. *p < 0.05, **p < 0.01, ***p < 0.001, Student’s t test.
(G) MOAP-1-deficient MEFs are less sensitive to the pro-apoptotic activity of Bax and tBid. WT and MOAP-1 KO MEFs were infected with retrovirus encoding
Myc-Bax or Myc-tBid for 24 hr. Cell death was determined using PI exclusion-based flow cytometric analysis as in (F). Percentages of cell death (mean ± SEM of
three independent experiments) are shown. *p < 0.05, Student’s t test.
(legend continued on next page)
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desensitizes whereas overexpression enhances the sensitivity of
cancer cells to chemotherapeutic drugs (Baksh et al., 2005; Fu
et al., 2007; Tan et al., 2005). Furthermore, effect of recombinant
Bax or tBid on inducing release of cytochrome c from isolated
mitochondria was impaired in mitochondria prepared from
the MOAP-1 knockdown cells (Tan et al., 2005), suggesting
MOAP-1 plays an important role in promoting activation of Bax
to regulate mitochondrial pathway of apoptosis.
Here, we reveal that MOAP-1-deficient mice are markedly
resistant to Fas-induced hepatocellular apoptosis and lethality.
Upon Fas induction, cleavage of Bid into tBid remains unaffected
in the MOAP-1-deficient livers. Interestingly, tBid is unable to
associate with MTCH2 and fails to accumulate at mitochondria
in the absence of MOAP-1. MOAP-1 associates with MTCH2,
but not tBid. Re-expression of MOAP-1, but not the MOAP-1
mutant defective in binding MTCH, in the MOAP-1-deficient an-
imals, restores the binding of tBid to MTCH2 and hepatocellular
apoptosis upon Fas activation. These data together suggest that
MOAP-1 serves as a critical component of the Fas signaling
in liver by promoting the mitochondrial receptor function of
MTCH2 for tBid.
RESULTS
Generation ofMOAP-1Knockout Mice and Evaluation of
Sensitivity of MOAP-1-Deficient MEFs to Multiple
Apoptotic Stimuli
To support investigation of the roles of MOAP-1 in regulating
mitochondrial apoptosis signaling pathway in vivo, targeting
vector to delete the exon 2 ofMOAP-1 covering the entire coding
region, was used for generating the knockout (KO) mice (Fig-
ure 1A). Genomic integration of the targeting vector was
confirmed by southern blotting (Figure 1A, right panel) and by
PCR-based genotyping (Figure 1B). Heterozygous parents pro-
duced offspring in accordance with theMendelian ratio. Deletion
of the gene in the KOmice was confirmed by RT-PCR (Figure 1C)
and western blotting of MOAP-1 protein in the liver (Figure 1D)
and in the mouse embryonic fibroblasts (MEFs) (Figure 1E).
MOAP-1 KO mice develop normally to adulthood and are fertile.
Similar to the observations made in the MOAP-1 knockdown
cells (Tan et al., 2005), MEFs derived from the MOAP-1 KO
mice showed a moderate reduction in sensitivity to multiple
apoptotic stimuli (Figure 1F). MOAP-1 KO MEFs also demon-
strated resistance to apoptosis induced by overexpression of
Bax or tBid (Figure 1G). Notably, isolated mitochondria prepared
from the MOAP-1 KO liver were markedly resistant to the
cytochrome c releasing effect of recombinant Bax and tBid
(Figure 1H).
MOAP-1-Deficient Mice Are Resistant to Fas-Induced
Lethality and Hepatocellular Apoptosis
In vivo activation of Fas signaling by tail vein injection with the
anti-Fas antibody (clone Jo-2) into mice is known to trigger(H) MOAP-1-deficient mitochondria from livers are markedly resistant to the
prepared from livers of the WT and MOAP-1 KO mice were incubated with
trations at 30C for 30 min before segregating the supernatant (Sup), which
mitochondria.
176 Cell Reports 16, 174–185, June 28, 2016massive apoptosis in liver via the mitochondrial pathway, fol-
lowed by lethality within hours (Ogasawara et al., 1993; Wei
et al., 2001; Yin et al., 1999). Because release of cytochrome c
from isolated mouse liver mitochondria induced by recombinant
Bax and tBid appeared critically dependent onMOAP-1, we sub-
jected theMOAP-1 KO mice to evaluation with this in vivo para-
digm. Young adult male wild-type (WT) and MOAP-1 KO mice
were given tail vein injection of the Jo-2 antibody. Remarkably,
while almost all the WT mice died within 16 hr (survival rate =
2/13), nearly all the MOAP-1 KO mice survived (survival rate =
13/15) at 24 hr post-injection (Figure 2A; Table S1).
We then analyzed the liver injury profile of theWT andMOAP-1
KOmice injected with Jo-2 antibody. In contrast to the WTmice,
serum levels of the liver injury marker, alanine aminotransferase
(ALT), were only slightly elevated in the MOAP-1 KO mice (Fig-
ure 2B). Histopathologic analysis of the H&E-stained sections re-
vealed significant hemorrhagic lesions in livers of the WT but not
MOAP-1 KOmice (Figure 2C, upper panels; Table S1). Similarly,
terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assay demonstrated massive apoptosis only in the
livers of the WT mice (Figure 2C, lower panels). Analysis of total
liver lysates prepared from the MOAP-1 KO mice subjected to
Jo-2 injection showed that caspase-8 activation remained unaf-
fected, while activation of caspase-3 and caspase-7 was signif-
icantly impaired (Figure 2D). Activation of caspase-9 (Figure 2D),
release of cytochrome c, Smac, and AIF to the cytosol (Fig-
ure 2E), and oligomerization of Bax and Bak (Figure 2F) were
all inhibited in the livers of the MOAP-1-deficient mice.
To confirm that MOAP-1 is required for mediating Fas
signaling in hepatocytes (type II cells), hepatocytes from the
WT andMOAP-1KOmice were prepared and subjected to treat-
ment with Jo-2 antibody plus actinomycin D (Act.D), which is an
established in vitro paradigm for Fas activation in hepatocytes
(Ni et al., 1994). Fas-induced activation of caspase-3, but not
caspase-8, was inhibited in the MOAP-1 KO hepatocytes (Fig-
ure S1A). Likewise, MOAP-1 KO hepatocytes treated with
increasing concentrations of recombinant Flag-tagged soluble
Fas ligand (FasL) plus anti-Flag antibody to activate Fas receptor
by aggregation (Jost et al., 2009), exhibited significant reduction
in cell death and caspase-3 activation (Figure S1B). In contrast
to hepatocytes, no notable difference in the sensitivity to the
FasL plus anti-Flag antibody treatment between the WT and
MOAP-1 KO thymocytes (type I cells) was noted (Figure S1C),
suggesting that MOAP-1 is primarily involved in facilitating Fas
signaling in the type II cells.
tBid Fails to Accumulate at Mitochondria in the Absence
of MOAP-1
Upon cleavage of Bid to tBid by activated caspase-8, tBid accu-
mulates at OMM to participate in the activation of the mitochon-
drial pathway of apoptosis that involves Bax and Bak (Gross
et al., 1999; Hikita et al., 2011; Lovell et al., 2008; Wei
et al., 2000, 2001). Because activation of caspase-8 upon Fascytochrome c releasing effect of recombinant Bax and tBid. Mitochondria
recombinant Bax (rBax) and tBid (rtBid) protein at the indicated concen-
harbors the released cytochrome c protein, from the pellet that contains
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Figure 2. MOAP-1-Deficient Mice Are Resis-
tant to Fas-Induced Lethality and Hepato-
cellular Apoptosis
(A) Kaplan-Meier survival curve of the 10- to 12-
week-old WT and MOAP-1 KO mice injected with
the Fas-activating antibody, Jo-2 (0.25 mg/g).
(B) Degree of liver injury in the WT and MOAP-1
KO mice mediated by in vivo Fas activation was
assessed by measuring serum alanine amino-
transferase (ALT) levels. WT andMOAP-1 KOmice
were injected with PBS (n = 3 per group) or Jo-2
(0.25 mg/g) (n = 6 for WT and n = 8 forMOAP-1 KO)
and the mice were euthanized at 200 min post-
injection. Error bars represent SEM. **p < 0.01,
Student’s t test.
(C) H&E staining (upper panels) and TUNEL label-
ing (lower panels) of liver sections from the mice
subjected to Jo-2 treatment as in (B). Scale bar,
100 mm.
(D) MOAP-1 is required for efficient activation
of caspase(casp)-3/7/9 but not casp-8. Western
analysis was conducted to assess the cleavage of
casp-8, casp-9, casp-3, and casp-7 in total liver
lysates from the WT and MOAP-1 KO mice sacri-
ficed at 200 min post-PBS or post-Jo-2 injection
(0.25 mg/g). Actin was probed to confirm uniform
loading.
(E) Cytosolic fraction of the liver lysates from mice
subjected to Jo-2 treatment as in (D) was analyzed
by western blotting for cytochrome c (cyt. c),
Smac, and AIF. Tubulin was used as an internal
loading control.
(F) Bax and Bak oligomerization in the mitochon-
drial lysates prepared from livers of mice subjected
to Jo-2 treatment as in (D) were determined via
crosslinking using bismaleimidohexane (BMH).
See also Figure S1 and Table S1.induction appeared unaffected in the absence of MOAP-1, we
examined levels of tBid in the mitochondrial and cytosolic
fractions of lysates prepared from livers and hepatocytes of
the WT and MOAP-1 KO mice injected with Jo-2 and treated
with Jo-2 plus Act.D, respectively. Interestingly, while generation
of tBid upon Fas activation was not affected, mitochondrial
accumulation of tBid was markedly hindered in the absence
of MOAP-1 (Figures 3A and 3B). When the time of analysis
was extended to 6 hr post-injection, similar observation was
noted (Figure S2A). To determine whether the requirement of
MOAP-1 for facilitatingmitochondrial recruitment of tBid is appli-
cable to other apoptotic stimuli and cell types, we examined
mitochondrial localization of tBid in HCT116 human colorectal
cancer cells and MEFs upon treatments with apoptotic stimuli
including TNF-related apoptosis-inducing ligand (TRAIL), thapsi-
gargin (THA), Jo-2 plus Act.D, or simply by overexpressing tBid.
In HCT116 cells treated with TRAIL or THA, knocking down
MOAP-1 did not affect production of tBid, but accumulation of
mitochondrial tBid as well as caspase-3 activation were inhibited
(Figures 3C, S2B, and S2C). In the MOAP-1 KO MEFs, diffuseCstaining pattern of Myc-tBid in the cytosol
were seen, which was distinct from the
punctate pattern associated with mito-chondria staining in the WT MEFs (Figure 3D). Moreover, in the
MOAP-1-deficient MEFs treated with Jo-2 plus Act.D, tBid also
failed to accumulate at mitochondria (Figures 3E and S2E).
Importantly, re-expression of MOAP-1 in the MOAP-1-deficient
MEFs restored the mitochondrial recruitment of tBid (Figure 3E).
Similarly, recombinant tBid (rtBid) associated avidly only with the
isolated mitochondria prepared from the WT, but not MOAP-1
KO livers (Figure 3F). Addition of recombinant GST-MOAP-1,
but not GST, to the MOAP-1-deficient mitochondria, was suffi-
cient to restore the association (Figure 3F). Furthermore, in
HCT116 cells treated with TRAIL or in MEFs treated with Jo-2
plus Act.D, higher levels of mitochondrial tBid were detected in
the cells overexpressing MOAP-1 (Figures S2D and S2F).
MOAP-1 Does Not Serve as a Direct Mitochondrial
Receptor for tBid
As MOAP-1 deficiency recapitulates loss of MTCH2 in prevent-
ing tBid recruitment to mitochondria (Zaltsman et al., 2010), we
hypothesized that MOAP-1 may also act as a mitochondrial re-
ceptor for tBid. To test the idea, we expressed Flag-MOAP-1ell Reports 16, 174–185, June 28, 2016 177
in the WT MEFs and subjected the cells to treatment with Jo-2
plus Act.D, followed by co-immunoprecipitation (coIP) assay.
Cells expressing Flag-MTCH2 were included as a positive con-
trol. In agreement with the previous observation that apoptotic
stimuli upregulate MOAP-1 (Fu et al., 2007), higher levels of
MOAP-1 was detected upon Fas induction (Figure 4A). In
contrast to MTCH2 that associates with tBid avidly, no notable
interaction between MOAP-1 and tBid was detected (Figure 4A).
Similarly, in HCT116 cells expressing Flag-MOAP-1 or Flag-
MTCH2 treated with TRAIL, only association of MTCH2 with
tBid could be detected (Figure 4B). Moreover, in HEK293T cells
overexpressing Myc-tBid and Flag-MTCH2 or Flag-MOAP-1,
only weak interaction was noted between MOAP-1 and tBid
(Figure 4C). Likewise, in vitro analysis also failed to detect any
binding between tBid and GST-MOAP-1, even though robust
tBid/Bcl-xL association was detected readily (Figure 4D), as
previously reported (Cheng et al., 2001; Li et al., 1998; Willis
et al., 2007).
MTCH2 Requires the Presence of MOAP-1 to Function
as a Mitochondrial Receptor for tBid
While MOAP-1 does not seem to facilitate mitochondrial recruit-
ment of tBid by serving as its receptor, it may modulate the
activity of MTCH2. Interestingly, in mice injected with Jo-2,
MTCH2/tBid interaction could only be detected in liver lysates
prepared from the WT but not MOAP-1 KO mice (Figures
5A and S3A). Furthermore, knockdown of MOAP-1 in the
HEK293T cells substantially reduced the interaction between
Myc-tBid and endogenous MTCH2 (Figure 5B). In vitro binding
assay by incubating total cell lysates with increasing concentra-
tions of recombinant tBid also demonstrated a dose-dependent
binding of rtBid to MTCH2 in the total cell lysates prepared from
the WT but not the MOAP-1 KO MEFs (Figures 5C). In MEFs
treated with Jo-2 plus Act.D, MTCH2/tBid interaction was
detected only in the WT MEFs (Figures 5D and S3B), and the
interaction was further enhanced by overexpressing MOAP-1
(Figures 5D and S3C). Moreover, MTCH2/tBid interaction in the
MOAP-1 KO MEFs was restored by re-expressing MOAP-1
(Figure 5D).
MOAP-1 Associates with MTCH2 and Fas Activation
Promotes Their Interaction
To understand how MOAP-1 regulates MTCH2/tBid interaction,
we studied the functional relationship between MOAP-1 and
MTCH2. First, we investigated whether MOAP-1 regulates the
abundance and mitochondrial localization of MTCH2 protein.
MTCH2 protein levels in the mitochondrial lysates from livers
(Figures S2A and S4F) and its mitochondrial localization patterns
in MEFs (Figures S2E and S4G) all appeared unaffected by the
absence of MOAP-1. To test whether MOAP-1 interacts with
MTCH2, we carried out coIP analysis. Interaction between
MOAP-1 andMTCH2was readily detected in mouse liver lysates
(Figure 6A). In HEK293T cells transfected with Flag-MTCH2 and
Myc-MOAP-1, MTCH2/MOAP-1 interaction could be demon-
strated in the coIP assays using either anti-Flag antibody (Fig-
ure S4A, upper panels) or anti-Myc antibody (Figure S4A, lower
panels). To confirm the interaction via an alternative approach,
we performed the Duolink proximity ligation assay (PLA) in the178 Cell Reports 16, 174–185, June 28, 2016MCF-7 cells. As working anti-MOAP-1 antibody for detecting
endogenous MOAP-1 by immunofluorescence is not yet avail-
able, we expressed Flag-MOAP-1 in these cells and performed
PLA using anti-Flag and anti-MTCH2 antibodies. As a negative
control, we included MTCH2 knockdown cells (Figures 6B and
S4B). Due to low transfection efficiency (15%), Duolink signals,
which represent theMOAP-1/MTCH2 interaction, were detected
on average two cells per view only in the Scramble but not
MTCH2 small hairpin RNA (shRNA)-expressing cells (Fig-
ure 6B). The signals from the Duolink system co-localized with
MitoTracker (Figure S4C), suggesting MOAP-1 associates with
MTCH2 at mitochondria. Interestingly, upon Fas activation,
MOAP-1/MTCH2 interaction was significantly enhanced in
the mouse livers (Figures 6C and S4D) and MEFs (Fig-
ure S4E). MOAP-1/MTCH2 interaction was also enhanced by
other apoptotic inducers, TRAIL and THA, in HCT116 cells
(Figure 6D).
Interaction of MOAP-1 with MTCH2 Is Necessary for
Mediating the Mitochondrial Receptor Function of
MTCH2 for tBid
To address the question whether MOAP-1/MTCH2 interaction is
required for mediating mitochondrial recruitment of tBid, we
began by usingmutagenesis analysis to identify regions of amino
acids (aa) of MOAP-1 that are required for the interaction with
MTCH2. A series of deletion mutants with 8–16 aa residues
of MOAP-1 removed at a time, were tested for their ability to
associate with MTCH2 (Figure S5A). The regions spanning
aa 1–119 (Figure S5B), aa 163–252 (Figures S5D and S5E) and
aa 294–351 (Figure S5E) were dispensable for the binding of
MOAP-1 to MTCH2, but aa 120–162 and aa 253–293 regions
ofMOAP-1 were necessary for mediating the interaction (Figures
S5C and S5E). Deletion mutants of MOAP-1 with only aa 115–
255 or aa 255–351 remaining, however, were unable to bind
MTCH2, although the aa 115–351 mutant, with the N-terminal
(aa 1–114) domain deleted, interacted efficiently with MTCH2
(Figure S5F), providing further evidence that both regions (aa
120–162 and aa 253–293) of MOAP-1 are required for establish-
ing essential contact points for stable binding with MTCH2. We
reported previously that aa 120–127 of MOAP-1 shares similar-
ities with the BH3 motif present among members of the Bcl-2
family including Bid (Tan et al., 2001). The amino acid sequence
in this region is 57% conserved among the MOAP-1 protein in
several mammalian species (Figure 7A). To define the key resi-
dues in this region required for the interaction with MTCH2,
several substitution mutants were evaluated (Figure 7A). Muta-
tions of the L120E and GHE/VLA but not the H126E in MOAP-1
were shown to abolish its interaction with Bax (Tan et al.,
2001). Interestingly, the L120E and GHE/VLA, but not H126E,
mutants of MOAP-1 also failed to interact with MTCH2, even
though their ability in associating with Bcl-xL (Figure 7B) and
localization to mitochondria (Figure 7D) remained unaltered. In
MCF-7 cells expressing Flag-tagged MOAP-1 or the L120E
mutant, the Duolink signals were detectable only in cells ex-
pressing MOAP-1, but not the L120E mutant (Figure S5G).
Next, we evaluated MOAP-1, the L120E, GHE/VLA, or H126E
mutant for their ability in rescuing the defect in MTCH2/tBid as-
sociation in theMOAP-1 KOMEFs. MOAP-1 and the H126E, but
AC
D
F
B
Bid
tBid
Bid
tBid
Bid
tBid
Mitochondria
Cytosol
Total liver lysates
WT MOAP-1 KO
PBS +
Jo-2 + +
+
+ +
VDAC1
-28 kDa 
-17 kDa
-10 kDa
-28 kDa 
-35 kDa 
-28 kDa 
-17 kDa
-10 kDa
-28 kDa 
-17 kDa
-10 kDa
 Jo-2 + Act.D
WT
Mitochondria
Total cell lysates
VDAC1
Bid
tBid
Bid
tBid
-28 kDa 
-17 kDa
-10 kDa
-28 kDa 
-35 kDa 
+ +
KO WT KO
 Mock + +
-28 kDa 
-17 kDa
-10 kDa
WT MOAP-1 KO
tBid
VDAC1
GST-MOAP-1
 Mitochondria
GST    +
+GST-MOAP-1
+
+
tBidInput
-28 kDa 
-35 kDa
-10 kDa
-17 kDa
-48 kDa
-63 kDa
GST -28 kDa
+rtBid ++ + + +
-10 kDa
-17 kDa
E
-28 kDa 
-17 kDa
-10 kDa
-35 kDa 
-28 kDa
-35 kDa
-28 kDa 
-17 kDa
-10 kDa
Mock
Mitochondria 
Total cell lysates
tBid
WT MOAP-1 KO
tBid
Bid
Retro-Myc-MOAP-1
Retro-EGFP + + + +
+ + + +
+Jo-2 + Act.D + ++
Bid
VDAC1
MOAP-1
++ ++
VDAC1
Bid
tBid
cleaved 
 casp-3
casp-3
Bid
tBid
Mock
TRAIL
Control shRNA
Mitochondria
Total cell lysates
MOAP-1 
+ +
+ +
-35 kDa 
-28 kDa
-17 kDa
-28 kDa 
-35 kDa
-17 kDa
+ +
+ +
-28 kDa 
-17 kDa
MOAP-1 shRNA
-10 kDa
WT MOAP-1 KO 
M
yc
-tB
id
TO
M
20
O
ve
rla
y  
D
A
P
I
D
A
P
I
  
Figure 3. MOAP-1 Is Required for Mitochondrial Accumulation of tBid
(A) Western analysis of tBid in the mitochondria, cytosol, and total lysates prepared from livers of theWT andMOAP-1 KOmice sacrificed at 200min post-PBS or
post-Jo-2 injection (0.25 mg/g). VDAC1 was probed as mitochondrial loading control.
(B) Hepatocytes prepared from the 10-week-oldWT andMOAP-1KOmiceweremock-treated or with Jo-2 (1 mg/ml) plus actinomycin D (Act.D) (0.1 mg/ml) for 4 hr
before total and mitochondrial lysates were prepared for western analysis.
(C) HCT116 cells were transfected with control or MOAP-1 shRNA. Two days post-transfection, cells were mock-treated or with TNF-related apoptosis-inducing
ligand (TRAIL) (100 ng/ml) for 3 hr and analyzed as in (A).
(D) tBid co-localizes with TOM20 (an OMM protein) only in the WT, but notMOAP-1 KOMEFs. WT andMOAP-1 KOMEFs were transiently transfected with Myc-
tBid and subjected to immunofluorescence with anti-Myc (red), anti-TOM20 (green), and DAPI (blue), followed by confocal analysis. Data from a single focal plane
is shown. Scale bar, 20 mm.
(legend continued on next page)
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Figure 4. MTCH2, Not MOAP-1, Is a Mito-
chondrial Receptor for tBid
(A) MTCH2, not MOAP-1, associates with tBid. WT
MEFs were infected with retrovirus encoding Flag-
MOAP-1 (Retro-Flag-MOAP-1) or Flag-MTCH2
(Retro-Flag-MTCH2) for 24 hr. Cells were then
mock-treated or with Jo-2 (1 mg/ml) and Act.D
(0.1 mg/ml) for 16 hr before preparing the total
lysates for immunoprecipitation (IP) analysis.
(B) HCT116 cells were transfected with Flag-
MOAP-1 or Flag-MTCH2 for 24 hr. Cells were then
mock-treated or with TRAIL (100 ng/ml) for 3 hr
before preparing the total lysates for IP analysis.
(C) HEK293T cells were transfected with Myc-tBid
and Flag-MTCH2 or Flag-MOAP-1. Sixteen hours
post-transfection, total cell lysates were subjected
to IP, followed by western blotting.
(D) MOAP-1 does not bind tBid in vitro. GST-
MOAP-1 or GST-Bcl-xL (2 mg/ml) was incubated
with 2 nM of rtBid for 2 hr before subjecting the
mixtures to GST pull-down. Eluates from the pull-
down and input (1% of the pre-pull-down mix-
tures) were analyzed by western blotting.not the L120E or GHE/VLA mutant, restored the MTCH2/tBid
interaction in the MOAP-1 KO MEFs (Figure 7C). As mitochon-
drial accumulation of tBid is facilitated through binding to
MTCH2, its recruitment to mitochondria was indeed restored in
the MOAP-1-deficient MEFs by re-expressing MOAP-1 and the
H126E, but not the L120E or GHE/VLA mutant or EGFP (Fig-
ure 7D). Moreover, in the MOAP-1 KO mice re-expressing
MOAP-1 but not the L120E mutant or EGFP, MTCH2/tBid inter-
action in liver upon in vivo Fas activation was re-established (Fig-
ure 7E). Importantly, mitochondrial accumulation of tBid in livers
and hepatocellular apoptosis in these KO mice were also effec-
tively restored by re-expressing MOAP-1, but not the L120E
mutant or EGFP (Figure 7F).
DISCUSSION
Fas-mediated activation of mitochondrial apoptosis signaling
could be regulated at multiple steps, including activation of
Fas receptor (Peter et al., 2007), assembly of death-inducing
signaling complex (DISC) (Kischkel et al., 1995), induction of cas-
pase-8 (Muzio et al., 1996), processing of Bid to tBid (Li et al.,
1998; Luo et al., 1998), mitochondrial accumulation of tBid
(Gross et al., 1999; Zaltsman et al., 2010), tBid-mediated activa-
tion and oligomerization of Bax and Bak (Kim et al., 2009; Lovell
et al., 2008; Wei et al., 2000, 2001) and releasing of cytochrome
c, Smac, and AIF frommitochondria into cytosol (Du et al., 2000;
Li et al., 1997; Susin et al., 1999; Verhagen et al., 2000). Protein-
protein interaction is a key regulatory paradigm amongmembers(E) Mitochondrial recruitment of tBid in the MOAP-1-deficient MEFs is restored
retrovirus encoding enhanced green fluorescence protein (Retro-EGFP) or Myc-t
mock treatment or with or Jo-2 (1 mg/ml) and Act.D (0.1 mg/ml) for 16 hr. Total and
(F) MOAP-1 is required for in vitro association of tBid with mitochondria. Mitochon
recombinant tBid (rtBid) (1 nM) and GST (500 ng/ml) or GST-MOAP-1 (100 ng/m
chondria, a higher amount of GST compared to GST-MOAP-1 was added to a
pelleted andwashed to remove unbound proteins before being subjected to weste
to ensure equal amount of tBid added to each sample.
See also Figure S2.
180 Cell Reports 16, 174–185, June 28, 2016of Bcl-2 family as both activation and inhibition of their activities
are frequently controlled by the proteins they interact with
(Czabotar et al., 2014). In this study, we uncovered a critical reg-
ulatory mechanism in the Fas-Bid signaling axis. Our data
demonstrate that MOAP-1 is a crucial component of Fas
signaling in liver. Recent data from Zaltsman et al. (2010) suggest
that mitochondrial accumulation of tBid is not a spontaneous
process, but is dependent on MTCH2 that serves as a recep-
tor-like protein for tBid. Surprisingly, our data show that the re-
ceptor function of MTCH2 in binding tBid requires interaction
with MOAP-1. It is likely that association of MOAP-1 with
MTCH2 induces conformation change in MTCH2 allowing it
to bind tBid avidly. While MOAP-1 appears to interact with
MTCH2 in resting cells, Fas and other apoptotic stimuli (that
were able to induce production of tBid) were shown to have a
significant effect for enhancing their interaction. The conforma-
tion states of MOAP-1 and MTCH2 in stimulated cells may un-
dergo further changes in MOAP-1, MTCH2, or both, and such
changes may serve to facilitate binding of tBid to MTCH2,
thereby recruitment of tBid to mitochondria. Further investi-
gation via structural analysis is necessary to gain deeper
understanding of the conformation states of MOAP-1/MTCH2
complex in the resting and apoptotic cells.
Because apoptotic stimuli also promoteMOAP-1/Bax interac-
tion (Tan et al., 2005), it is conceivable that protein complexes
containing unknown and known factors including tBid, MTCH2,
MOAP-1, or Bax may exist at different stages of the signaling
process to coordinate sequential molecular events leading toby re-expressing MOAP-1. WT and MOAP-1 KO MEFs were infected with
agged MOAP-1 (Retro-Myc-MOAP-1) for 24 hr before subjecting the MEFs to
mitochondrial lysates were then prepared from the MEFs for western analysis.
dria prepared from the WT andMOAP-1 KOmouse livers were incubated with
l) at 30C for 30 min. Because GST-MOAP-1 is readily accumulated at mito-
chieve comparable levels at mitochondria. Mitochondria were subsequently
rn analysis. One percent of the pre-bindingmixtures were included as the input
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Figure 5. Association of tBid with MTCH2
Requires the Presence of MOAP-1
(A) tBid is unable to associate with MTCH2 in the
absence of MOAP-1. Total liver lysates prepared
from WT and MOAP-1 KO mice at 200 min post-
PBS or post-Jo-2 injection (0.25 mg/g) were sub-
jected to IP, followed by western analysis.
(B) Association of tBid with MTCH2 is substan-
tially weakened in the MOAP-1 knockdown cells.
HEK293T cells were transfected with the control or
MOAP-1 shRNA. Forty-eight hours later, cells
were transfected with Myc-tBid for 16 hr before
subjecting the total cell lysates to IP analysis and
western blotting.
(C) MOAP-1 is required for in vitro association
of tBid with MTCH2. Total cell lysates of WT or
MOAP-1 KO MEFs were incubated with the indi-
cated concentrations of rtBid for 2 hr before sub-
jecting to IP, followed by western analysis. Inputs
(1% of the pre-IP mixtures) were shown to docu-
ment the increasing amounts of rtBid added to the
lysates.
(D) Association of tBid with MTCH2 in MOAP-1-
deficient MEFs is restored by re-expressing MOAP-1. WT and MOAP-1 KO MEFs were infected with Retro-EGFP or Retro-Myc-MOAP-1 for 24 hr before
subjecting the MEFs to mock treatment or with Jo-2 (1 mg/ml) and Act.D (0.1 mg/ml) for 16 hr, followed by IP and western blotting.
See also Figure S3.oligomerization of Bax. Failure in detectingMOAP-1/tBid associ-
ation raises the question of the presence of a stable protein
complex containing MOAP-1, MTCH2, tBid, and Bax. However,
protein signaling complexes involving members of Bcl-2 family
such as tBid and Bax have also been shown to exist in transient
states or in a ‘‘hit/kiss-and-run’’ manner (Chen et al., 2015; Cza-
botar et al., 2014; Lovell et al., 2008; Shamas-Din et al., 2014;
Willis et al., 2007), which create technical challenges for detect-
ing and identifying individual component in the protein com-
plexes with conventional biochemical techniques. Interestingly,
the BH3-like motif in MOAP-1 required for binding Bax (Tan
et al., 2001) is also found to be necessary for mediating interac-
tion with MTCH2, raising the question whether the two proteins
bind to similar regions of MOAP-1. Engagement of Bax in the
apoptotic signaling process is known to occur in a sequential
manner, from conformational change, translocation to mito-
chondria, insertion into OMM, to oligomerization (Czabotar
et al., 2013; Kim et al., 2009; Lovell et al., 2008). Inhibition of
Bax and Bak oligomerization in the absence of MOAP-1 could
be due to deficiency in activation of upstream signaling facili-
tated by mitochondrial tBid, but it may also be possible that
MOAP-1 interaction with Bax during apoptosis or in co-opera-
tion with tBid/Bax plays a role in promoting Bax oligomerization.
Interestingly, MOAP-1 deficiency appears to be more protective
thanMTCH2 deficiency from the Fas-induced lethality (Zaltsman
et al., 2010). Furthermore, in contrast to the MOAP-1 KO
MEFs (Figure 1G),MTCH2 KO MEFs were not protected against
Bax-induced apoptosis (Zaltsman et al., 2010), providing sup-
port to the argument that MOAP-1 may regulate the Fas
apoptotic signaling through both upstream (mitochondrial
targeting of tBid) and downstream (oligomerization of Bax)
signaling events.
Martinou and colleagues (Raemy et al., 2016) have recently
confirmed that MTCH2 is critical for tBid recruitment in HeLacells, but in HCT116 cells, MTCH2 and cardiolipin appear to
play a redundant role in facilitating mitochondrial recruitment
of tBid. However, our data demonstrated that depletion of
MOAP-1 is sufficient to abolish mitochondrial accumulation of
tBid and inhibit apoptosis in several type II cells including hepa-
tocytes and HCT116 cells (Figures 3A–3C, S1B, S2B, and S2C).
While this observation offers evidence to support the critical role
of MOAP-1 in promoting the receptor function of MTCH2 for
tBid, additional mechanisms in facilitating mitochondrial accu-
mulation of tBid and Bax activation such as regulation of cardi-
olipin levels or its transport across the mitochondrial mem-
branes during apoptosis, which may also be dependent on the
presence of MOAP-1, cannot be ruled out.
In contrast to the Bid KO (Yin et al., 1999) and MOAP-1 KO
mice, which display no developmental or fertility defects,
MTCH2 KO is embryonic lethal (Zaltsman et al., 2010), under-
scoring its essential role during embryonic development.
MTCH2 has recently been shown to play a role in regulatingmito-
chondrial oxidative phosphorylation (OXPHOS) and mitochon-
drial size/volume in hematopoietic stem cells and muscles
(Buzaglo-Azriel et al., 2016; Maryanovich et al., 2015). It remains
to be studied whether MOAP-1 can co-operate with MTCH2 to
participate in the regulation of metabolism and mitochondrial
OXPHOS and size/volume.
Identifying the role of MOAP-1 in regulating Fas signaling in
mitochondrial pathway of apoptosis would open up interesting
opportunities for investigating the roles of MOAP-1 in the devel-
opment of human liver diseases underpinned by Fas signaling
mechanism such as fulminant hepatitis, cirrhosis, and Wilson’s
disease (Guicciardi and Gores, 2005; Peter et al., 2007). Owing
to the potentially druggable property of MOAP-1 by being
a direct substrate of the UPS (Fu et al., 2007), MOAP-1 can
be explored as a therapeutic target for treatment of certain liver
diseases associated with dysfunction of Fas signaling.Cell Reports 16, 174–185, June 28, 2016 181
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Figure 6. MOAP-1 Associates with MTCH2 and the Interaction Is Enhanced by Fas Activation
(A) MOAP-1 associates with MTCH2 in liver. Total lysates prepared from livers of the WT and MOAP-1 KO mice were subjected to IP, followed by western
analysis. HSP60 was probed to ensure equal input for IP.
(B) Interaction between MOAP-1 and MTCH2 is demonstrated by the proximity ligation assay (PLA). MCF-7 cells expressing Scramble or MTCH2 shRNA were
transfected with Flag-MOAP-1 for 24 hr before subjecting the cells to the PLA via the Duolink method, followed by confocal microscopic analysis. Maximal
intensity projection of a z stack containing twenty 0.5-mm thick focal planes is shown (top panels). Nuclei were stained with DAPI (in blue). Scale bar, 20 mm. Total
cell lysates of MCF-7 cells expressing Scramble or MTCH2 shRNA and transfected with Flag-MOAP-1 were analyzed by western blotting to confirm comparable
Flag-MOAP-1 expression and efficient MTCH2 knockdown (bottom panels).
(C) Fas activation enhances MOAP-1/MTCH2 interaction. Total liver lysates prepared from WT and MOAP-1 KO mice at 200 min post-PBS or post-Jo-2
(0.25 mg/g) were subjected to IP, followed by western analysis.
(D) Apoptotic stimuli enhance the MOAP-1/MTCH2 interaction. HCT116 cells were treated with DMSO, TRAIL (100 ng/ml) for 3 hr or THA (10 mM) for 12 hr. Total
cell lysates were prepared for IP and western analysis.
See also Figure S4.EXPERIMENTAL PROCEDURES
Mice
MOAP-1KOmice were first generated in the 129 genetic background. The tar-
geting vector was designed to replace the exon 2 ofMOAP-1, which contains
the entire coding region of the gene, with the neomycin cassette via homolo-
gous recombination. The linearized targeting vectorwas introduced intomurine
embryonic stem cells via electroporation. Southern blot analysis was carried
out to confirm homologous recombination within the MOAP-1 gene locus in
the neomycin-resistant clones before blastocyst injection as previously
described (Yin et al., 1999). The mutant allele in the MOAP-1 locus was
confirmed in the first generation ofMOAP-1+/mice derived from the chimeras
by southern blotting and the subsequent genotyping of mice was performed
using PCR-based assay as described (Zaltsman et al., 2010). Heterozygous
micewere backcrossedwith the C57/BL6 strain for more than ten generations.
Bothwild-typeandMOAP-1KOmice used for experimentswere from the same
heterozygous founders in pure C57/BL6 genetic background and were in-bred
for no more than six generations. Mice were weaned at the age of 21 days and
maintained on the Chow diet and 12 hr light/12 hr dark cycle at 23C.
For the in vivo paradigm of Fas activation, 10- to 12-week-old MOAP-1
knockout or wild-type control male mice were injected with anti-Fas antibody
(clone Jo-2, BD Biosciences) via tail vein at the dose of 0.25 mg/g body weight.182 Cell Reports 16, 174–185, June 28, 2016Animal survival was monitored every hour for 24 hr. For tissue harvest, mice
were euthanized at the indicated times post-injection by CO2 asphyxiation.
All animal procedures were carried out with evaluation and oversight from
the Institutional Animal Care and Use Committee (IACUC) and conducted
in compliance with the National Advisory Committee for Laboratory Animal
Research (NACLAR) guidelines.
Mitochondria Isolation
Mitochondria-enriched heavy membrane fraction was isolated as previously
described (Sukumaran et al., 2010). Briefly, 30 mg of liver tissues (or near
confluent 15 cm dish of MEFs or 10 cm dish of hepatocytes or HCT116 cells)
were homogenized in 1 ml of mitochondrial isolation buffer (50 mM HEPES-
KOH [pH 7.5], 320 mM sucrose, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA,
1 mMDTT and protease inhibitor cocktail) by passing through a Dounce tissue
grinder eight times. Cell suspension was disrupted by 20 expulsions through a
25G needle and centrifuged at 800 3 g for 10 min to remove cell debris and
nuclei. The supernatant was then centrifuged at 10,0003 g for 20 min to pellet
the mitochondria. The supernatant was collected as the cytosolic fraction.
Immunoprecipitation
Immunoprecipitation (IP) assays were performed as previously described (Su-
kumaran et al., 2010). Liver tissues (30mg) were homogenized in 1ml IP lysis
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Figure 7. Association of MOAP-1 with MTCH2 Is Required for Engaging the Receptor Function of MTCH2 for tBid
(A) Illustration depicting the two regions of MOAP-1 required for mediating interaction with MTCH2. ClustalW2 alignment of the BH3-like domain of MOAP-1
among the indicated mammalian species. *Indicates the positions that have a single, fully conserved residue; whereas (:) and (.) indicate conservation
between groups of strongly similar and weakly similar properties, respectively. The coordinates of the substitution mutants, L120E, GHE/VLA, and H126E
are shown.
(B) The L120E and GHE/VLA, but not H126E, mutants of MOAP-1 within the BH3-like domain fail to interact with MTCH2. HEK293T cells were transfected with
empty vector, Flag-tagged MOAP-1 or the mutants (L120E, GHE/VLA, and H126E). Total cell lysates were subjected to IP, followed by western analysis.
(legend continued on next page)
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buffer (50mMTris [pH 7.5], 150mMNaCl, 1% Triton X-100, 2mMEDTA, 2mM
Na2H2PO4, 10% glycerol and protease inhibitor cocktail) using a Dounce tis-
sue grinder and incubated on ice for 2 hr. For cells, they were scrapped off
in 1 ml IP lysis buffer and incubated on ice for 30 min. Tissue/cell lysates
were centrifuged at 21,000 3 g for 20 min to remove cell debris, and 5 mg
of the lysates were incubated at 4C overnight with Protein-A agarose beads
(Roche) pre-bound with 5–10 mg of antibodies. Beads were washed four times
with IP lysis buffer and eluted in 13 sample buffer.
Statistical Analysis
Statistical differences between two sets of data were analyzed in GraphPad
Prism using Student’s t test (unpaired, non-parametric) or c2 test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.05.068.
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See also Figure S5.
184 Cell Reports 16, 174–185, June 28, 2016REFERENCES
Baksh, S., Tommasi, S., Fenton, S., Yu, V.C., Martins, L.M., Pfeifer, G.P., Latif,
F., Downward, J., and Neel, B.G. (2005). The tumor suppressor RASSF1A and
MAP-1 link death receptor signaling to Bax conformational change and cell
death. Mol. Cell 18, 637–650.
Buzaglo-Azriel, L., Kuperman, Y., Tsoory, M., Zaltsman, Y., Shachnai, L., Zaid-
man, S.L., Bassat, E., Michailovici, I., Sarver, A., Tzahor, E., et al. (2016). Loss
of muscle MTCH2 increases whole-body energy utilization and protects from
diet-induced obesity. Cell Rep. 14, 1602–1610.
Chen, H.C., Kanai, M., Inoue-Yamauchi, A., Tu, H.C., Huang, Y., Ren, D., Kim,
H., Takeda, S., Reyna, D.E., Chan, P.M., et al. (2015). An interconnected hier-
archical model of cell death regulation by the BCL-2 family. Nat. Cell Biol. 17,
1270–1281.
Cheng, E.H., Wei, M.C., Weiler, S., Flavell, R.A., Mak, T.W., Lindsten, T., and
Korsmeyer, S.J. (2001). BCL-2, BCL-X(L) sequester BH3 domain-only mole-
cules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol.
Cell 8, 705–711.
Czabotar, P.E., Westphal, D., Dewson, G., Ma, S., Hockings, C., Fairlie, W.D.,
Lee, E.F., Yao, S., Robin, A.Y., Smith, B.J., et al. (2013). Bax crystal structures
reveal how BH3 domains activate Bax and nucleate its oligomerization to
induce apoptosis. Cell 152, 519–531.
Czabotar, P.E., Lessene, G., Strasser, A., and Adams, J.M. (2014). Control of
apoptosis by the BCL-2 protein family: implications for physiology and ther-
apy. Nat. Rev. Mol. Cell Biol. 15, 49–63.
Du, C., Fang, M., Li, Y., Li, L., andWang, X. (2000). Smac, a mitochondrial pro-
tein that promotes cytochrome c-dependent caspase activation by eliminating
IAP inhibition. Cell 102, 33–42.
Esposti, M.D., Cristea, I.M., Gaskell, S.J., Nakao, Y., and Dive, C. (2003). Pro-
apoptotic Bid binds to monolysocardiolipin, a new molecular connection
between mitochondrial membranes and cell death. Cell Death Differ. 10,
1300–1309.
Fu, N.Y., Sukumaran, S.K., and Yu, V.C. (2007). Inhibition of ubiquitin-medi-
ated degradation of MOAP-1 by apoptotic stimuli promotes Bax function in
mitochondria. Proc. Natl. Acad. Sci. USA 104, 10051–10056.
Fu, N.Y., Sukumaran, S.K., Kerk, S.Y., and Yu, V.C. (2009). Baxbeta: a consti-
tutively active human Bax isoform that is under tight regulatory control by the
proteasomal degradation mechanism. Mol. Cell 33, 15–29.
Galle, P.R., Hofmann, W.J., Walczak, H., Schaller, H., Otto, G., Stremmel, W.,
Krammer, P.H., and Runkel, L. (1995). Involvement of the CD95 (APO-1/Fas)
receptor and ligand in liver damage. J. Exp. Med. 182, 1223–1230.
Grinberg, M., Schwarz, M., Zaltsman, Y., Eini, T., Niv, H., Pietrokovski, S., and
Gross, A. (2005). Mitochondrial carrier homolog 2 is a target of tBID in cells
signaled to die by tumor necrosis factor alpha. Mol. Cell. Biol. 25, 4579–4590.
Gross, A., Yin, X.M., Wang, K., Wei, M.C., Jockel, J., Milliman, C., Erdjument-
Bromage, H., Tempst, P., and Korsmeyer, S.J. (1999). Caspase cleaved BID
targets mitochondria and is required for cytochrome c release, while BCL-XL
prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol.
Chem. 274, 1156–1163., restore MTCH2/tBid interaction in the MOAP-1-deficient MEFs.MOAP-1 KO
24 hr, before treatment with Jo-2 (1 mg/ml) plus Act.D (0.1 mg/ml) for 16 hr. Total
nts, L120E or GHE/VLA, are able to restore mitochondrial recruitment of tBid in
g MOAP-1 or the indicated mutants for 24 hr, followed by treatment with Jo-2
analysis.
Fas activation in the MOAP-1-deficient mice.MOAP-1 KO mice were injected
ty-four hours later, mice were injected with Jo-2 (0.25 mg/g) and euthanized at
re subjected to IP, followed by western blotting.
in the MOAP-1-deficient mice by re-expressing MOAP-1, but not the L120E
P-1, or the L120E mutant. Twenty-four hours later, the mice were subjected to
from livers of these mice for western analysis. Hepatocellular apoptosis was
-7 and their substrate PARP.
Guicciardi, M.E., andGores, G.J. (2005). Apoptosis: amechanism of acute and
chronic liver injury. Gut 54, 1024–1033.
Hikita, H., Takehara, T., Kodama, T., Shimizu, S., Shigekawa, M., Hosui, A.,
Miyagi, T., Tatsumi, T., Ishida, H., Li, W., et al. (2011). Delayed-onset cas-
pase-dependent massive hepatocyte apoptosis upon Fas activation in Bak/
Bax-deficient mice. Hepatology 54, 240–251.
Jost, P.J., Grabow, S., Gray, D., McKenzie, M.D., Nachbur, U., Huang, D.C.,
Bouillet, P., Thomas, H.E., Borner, C., Silke, J., et al. (2009). XIAP discriminates
between type I and type II FAS-induced apoptosis. Nature 460, 1035–1039.
Kim, H., Tu, H.C., Ren, D., Takeuchi, O., Jeffers, J.R., Zambetti, G.P., Hsieh,
J.J., and Cheng, E.H. (2009). Stepwise activation of BAX and BAK by tBID,
BIM, and PUMA initiates mitochondrial apoptosis. Mol. Cell 36, 487–499.
Kischkel, F.C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer,
P.H., and Peter, M.E. (1995). Cytotoxicity-dependent APO-1 (Fas/CD95)-
associated proteins form a death-inducing signaling complex (DISC) with the
receptor. EMBO J. 14, 5579–5588.
Lazic,M., Eguchi, A., Berk, M.P., Povero, D., Papouchado, B.,Mulya, A., John-
son, C.D., and Feldstein, A.E. (2014). Differential regulation of inflamma-
tion and apoptosis in Fas-resistant hepatocyte-specific Bid-deficient mice.
J. Hepatol. 61, 107–115.
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S.,
andWang, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/
caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479–489.
Li, H., Zhu, H., Xu, C.J., and Yuan, J. (1998). Cleavage of BID by caspase 8me-
diates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94,
491–501.
Lovell, J.F., Billen, L.P., Bindner, S., Shamas-Din, A., Fradin, C., Leber, B., and
Andrews, D.W. (2008). Membrane binding by tBid initiates an ordered series of
events culminating in membrane permeabilization by Bax. Cell 135, 1074–
1084.
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. (1998). Bid, a Bcl2
interacting protein, mediates cytochrome c release from mitochondria in
response to activation of cell surface death receptors. Cell 94, 481–490.
Lutter, M., Fang, M., Luo, X., Nishijima, M., Xie, X., and Wang, X. (2000). Car-
diolipin provides specificity for targeting of tBid to mitochondria. Nat. Cell Biol.
2, 754–761.
Maryanovich, M., Zaltsman, Y., Ruggiero, A., Goldman, A., Shachnai, L., Zaid-
man, S.L., Porat, Z., Golan, K., Lapidot, T., and Gross, A. (2015). An MTCH2
pathway repressing mitochondria metabolism regulates haematopoietic
stem cell fate. Nat. Commun. 6, 7901.
Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O’Rourke, K., Shevchenko, A., Ni,
J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel
FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/
APO-1) death–inducing signaling complex. Cell 85, 817–827.
Ni, R., Tomita, Y., Matsuda, K., Ichihara, A., Ishimura, K., Ogasawara, J., and
Nagata, S. (1994). Fas-mediated apoptosis in primary cultured mouse hepato-
cytes. Exp. Cell Res. 215, 332–337.
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai,
T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S. (1993). Lethal effect of the
anti-Fas antibody in mice. Nature 364, 806–809.
Peter, M.E., Budd, R.C., Desbarats, J., Hedrick, S.M., Hueber, A.O., Newell,
M.K., Owen, L.B., Pope, R.M., Tschopp, J., Wajant, H., et al. (2007). The
CD95 receptor: apoptosis revisited. Cell 129, 447–450.
Raemy, E., Montessuit, S., Pierredon, S., van Kampen, A.H., Vaz, F.M., and
Martinou, J.C. (2016). Cardiolipin or MTCH2 can serve as tBID receptors dur-
ing apoptosis. Cell Death Differ. Published online January 22, 2016. http://dx.
doi.org/10.1038/cdd.2015.166.Ryo, K., Kamogawa, Y., Ikeda, I., Yamauchi, K., Yonehara, S., Nagata, S., and
Hayashi, N. (2000). Significance of Fas antigen-mediated apoptosis in human
fulminant hepatic failure. Am. J. Gastroenterol. 95, 2047–2055.
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K.J., Deba-
tin, K.M., Krammer, P.H., and Peter, M.E. (1998). Two CD95 (APO-1/Fas)
signaling pathways. EMBO J. 17, 1675–1687.
Shamas-Din, A., Satsoura, D., Khan, O., Zhu, W., Leber, B., Fradin, C., and
Andrews, D.W. (2014). Multiple partners can kiss-and-run: Bax transfers
between multiple membranes and permeabilizes those primed by tBid. Cell
Death Dis. 5, e1277.
Strasser, A., Jost, P.J., and Nagata, S. (2009). The many roles of FAS receptor
signaling in the immune system. Immunity 30, 180–192.
Sukumaran, S.K., Fu, N.Y., Tin, C.B., Wan, K.F., Lee, S.S., and Yu, V.C. (2010).
A soluble form of the pilus protein FimA targets the VDAC-hexokinase complex
at mitochondria to suppress host cell apoptosis. Mol. Cell 37, 768–783.
Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Snow, B.E., Brothers, G.M.,
Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999). Molecular
characterization of mitochondrial apoptosis-inducing factor. Nature 397,
441–446.
Tan, K.O., Tan, K.M., Chan, S.L., Yee, K.S., Bevort, M., Ang, K.C., and Yu, V.C.
(2001). MAP-1, a novel proapoptotic protein containing a BH3-like motif that
associates with Bax through its Bcl-2 homology domains. J. Biol. Chem.
276, 2802–2807.
Tan, K.O., Fu, N.Y., Sukumaran, S.K., Chan, S.L., Kang, J.H., Poon, K.L.,
Chen, B.S., and Yu, V.C. (2005). MAP-1 is a mitochondrial effector of Bax.
Proc. Natl. Acad. Sci. USA 102, 14623–14628.
Verhagen, A.M., Ekert, P.G., Pakusch, M., Silke, J., Connolly, L.M., Reid, G.E.,
Moritz, R.L., Simpson, R.J., and Vaux, D.L. (2000). Identification of DIABLO, a
mammalian protein that promotes apoptosis by binding to and antagonizing
IAP proteins. Cell 102, 43–53.
Wang, K., Yin, X.M., Chao, D.T., Milliman, C.L., and Korsmeyer, S.J. (1996).
BID: a novel BH3 domain-only death agonist. Genes Dev. 10, 2859–2869.
Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., and
Nagata, S. (1992). Lymphoproliferation disorder in mice explained by defects
in Fas antigen that mediates apoptosis. Nature 356, 314–317.
Wei, M.C., Lindsten, T., Mootha, V.K., Weiler, S., Gross, A., Ashiya, M.,
Thompson, C.B., and Korsmeyer, S.J. (2000). tBID, a membrane-targeted
death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14,
2060–2071.
Wei, M.C., Zong,W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou, V., Ross,
A.J., Roth, K.A., MacGregor, G.R., Thompson, C.B., and Korsmeyer, S.J.
(2001). Proapoptotic BAX and BAK: a requisite gateway to mitochondrial
dysfunction and death. Science 292, 727–730.
Willis, S.N., Fletcher, J.I., Kaufmann, T., van Delft, M.F., Chen, L., Czabotar,
P.E., Ierino, H., Lee, E.F., Fairlie, W.D., Bouillet, P., et al. (2007). Apoptosis initi-
ated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak.
Science 315, 856–859.
Yerushalmi, G.M., Leibowitz-Amit, R., Shaharabany, M., and Tsarfaty, I.
(2002). Met-HGF/SF signal transduction induces mimp, a novel mitochondrial
carrier homologue, which leads to mitochondrial depolarization. Neoplasia 4,
510–522.
Yin, X.M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K.A., and
Korsmeyer, S.J. (1999). Bid-deficient mice are resistant to Fas-induced hepa-
tocellular apoptosis. Nature 400, 886–891.
Zaltsman, Y., Shachnai, L., Yivgi-Ohana, N., Schwarz, M., Maryanovich, M.,
Houtkooper, R.H., Vaz, F.M., De Leonardis, F., Fiermonte, G., Palmieri, F.,
et al. (2010). MTCH2/MIMP is a major facilitator of tBID recruitment to mito-
chondria. Nat. Cell Biol. 12, 553–562.Cell Reports 16, 174–185, June 28, 2016 185
